Aarti Pharmalabs Ltd.
•₹ 816.8-1.5%
2026-08-21
PROS
- Latest quarter profit grew 53.8% YoY, showing strong momentum
- Operating margins have improved to 22.0% from 17.5%
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.17x)
- Company comfortably covers its interest (14.4x coverage)
- Company generates healthy free cash flow
- Company maintains a comfortable, low leverage position
CONS
- Recent results are weak - TTM profit is down 21.7% versus prior year
- Promoter holding has decreased over last 2 years: -3.6pp
- Total debt has risen sharply - up 50.1% year on year
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | AARTIPHARM | 834.70 | 35.51 | 7569.04 | 0.42 | 761.43 | 1554.17 | 5357.97 | 1287.39 | 17.59 | 26.78 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 458 | 440 | 449 | 506 | 555 | 458 | 538 | 564 | 386 | 418 | 432 | 583 | 536 | |
| 373 | 352 | 353 | 388 | 459 | 364 | 409 | 421 | 291 | 344 | 330 | 470 | 443 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 0 | 1 | 1 | 2 | 2 | 4 | 5 | 1 | 2 | 0 | -0 | 8 | 0 |
| Interest | 4 | 4 | 4 | 5 | 5 | 6 | 10 | 7 | 7 | 11 | 13 | 17 | 13 |
| Depreciation | 17 | 18 | 19 | 19 | 20 | 21 | 23 | 23 | 23 | 25 | 29 | 28 | 30 |
| 64 | 67 | 74 | 96 | 74 | 72 | 101 | 115 | 67 | 39 | 58 | 76 | 101 | |
| Tax % | 26.38% | 22.61% | 28.53% | 31.85% | 24.73% | 23.90% | 26.47% | 22.93% | 23.72% | 27.38% | 25.73% | 26.99% | 24.66% |
| Net Profit | 0 | 0 | 0 | 0 | 55 | 55 | 74 | 88 | 50 | 28 | 48 | 61 | 76 |
| 5 | 6 | 6 | 7 | 6 | 6 | 8 | 10 | 5 | 3 | 5 | 7 | 1 | |
| Equity Capital | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 | 45 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 458
- 373
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 4
- Depreciation
- 17
- 64
- Tax %
- 26.38%
- Net Profit
- 0
- 5
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 440
- 352
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 4
- Depreciation
- 18
- 67
- Tax %
- 22.61%
- Net Profit
- 0
- 6
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 449
- 353
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 4
- Depreciation
- 19
- 74
- Tax %
- 28.53%
- Net Profit
- 0
- 6
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 506
- 388
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 5
- Depreciation
- 19
- 96
- Tax %
- 31.85%
- Net Profit
- 0
- 7
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 555
- 459
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 5
- Depreciation
- 20
- 74
- Tax %
- 24.73%
- Net Profit
- 55
- 6
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 458
- 364
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 6
- Depreciation
- 21
- 72
- Tax %
- 23.90%
- Net Profit
- 55
- 6
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 538
- 409
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 10
- Depreciation
- 23
- 101
- Tax %
- 26.47%
- Net Profit
- 74
- 8
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 564
- 421
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 7
- Depreciation
- 23
- 115
- Tax %
- 22.93%
- Net Profit
- 88
- 10
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 386
- 291
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 7
- Depreciation
- 23
- 67
- Tax %
- 23.72%
- Net Profit
- 50
- 5
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 418
- 344
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 11
- Depreciation
- 25
- 39
- Tax %
- 27.38%
- Net Profit
- 28
- 3
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 432
- 330
- Operating Profit
- —
- OPM %
- —
- Other Income
- -0
- Interest
- 13
- Depreciation
- 29
- 58
- Tax %
- 25.73%
- Net Profit
- 48
- 5
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 583
- 470
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 17
- Depreciation
- 28
- 76
- Tax %
- 26.99%
- Net Profit
- 61
- 7
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 536
- 443
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 13
- Depreciation
- 30
- 101
- Tax %
- 24.66%
- Net Profit
- 76
- 1
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| 0 | 1,200 | 1,945 | 1,853 | 2,115 | 1,969 | |
| 0 | 995 | 1,603 | 1,467 | 1,651 | 1,586 | |
| Operating Profit | -0 | 209 | 344 | 391 | 474 | — |
| OPM % | — | 17 | 18 | 21 | 22 | — |
| Other Income | 0 | 4 | 2 | 5 | 10 | 8 |
| Interest | 0 | 12 | 21 | 17 | 27 | 53 |
| Depreciation | 0 | 42 | 63 | 73 | 87 | 112 |
| -0 | 155 | 261 | 300 | 361 | 275 | |
| Tax % | 0 | 21 | 26 | 28 | 24 | 26 |
| Net Profit | -0 | 122 | 193 | 217 | 272 | 203 |
| EPS | -0 | 13 | 21 | 24 | 30 | — |
| Dividend Payout % | 0 | 0 | 9 | 13 | 17 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 17 |
| Adjusted EPS | -0 | 4,890 | 21 | 24 | 30 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 17 |
| Adjusted EPS | -0 | 4,890 | 21 | 24 | 30 | — |
Mar 2021
- 0
- 0
- Operating Profit
- -0
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 0
- -0
- Tax %
- 0
- Net Profit
- -0
- EPS
- -0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -0
Mar 2022
- 1,200
- 995
- Operating Profit
- 209
- OPM %
- 17
- Other Income
- 4
- Interest
- 12
- Depreciation
- 42
- 155
- Tax %
- 21
- Net Profit
- 122
- EPS
- 13
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4,890
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4,890
Mar 2023
- 1,945
- 1,603
- Operating Profit
- 344
- OPM %
- 18
- Other Income
- 2
- Interest
- 21
- Depreciation
- 63
- 261
- Tax %
- 26
- Net Profit
- 193
- EPS
- 21
- Dividend Payout %
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 21
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 21
Mar 2024
- 1,853
- 1,467
- Operating Profit
- 391
- OPM %
- 21
- Other Income
- 5
- Interest
- 17
- Depreciation
- 73
- 300
- Tax %
- 28
- Net Profit
- 217
- EPS
- 24
- Dividend Payout %
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 24
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 24
Mar 2025
- 2,115
- 1,651
- Operating Profit
- 474
- OPM %
- 22
- Other Income
- 10
- Interest
- 27
- Depreciation
- 87
- 361
- Tax %
- 24
- Net Profit
- 272
- EPS
- 30
- Dividend Payout %
- 17
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 30
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 30
TTM
- 1,969
- 1,586
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 53
- Depreciation
- 112
- 275
- Tax %
- 26
- Net Profit
- 203
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 17
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 17
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 21%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 31%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 31%
- 1 Year:
- -1%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 11%
- 3 Years:
- 14%
- Last Year:
- 15%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| LIABILITIES | - | - | - | - |
| Equity Capital | 0 | 45 | 45 | 45 |
| 1,341 | 1,513 | 1,711 | 1,943 | |
| 338 | 214 | 264 | 293 | |
| Trade Payables | 215 | 340 | 378 | 278 |
| 146 | 132 | 183 | 348 | |
| Total Liabilities | 2,040 | 2,244 | 2,582 | 2,906 |
| ASSETS | - | - | - | - |
| 782 | 926 | 1,033 | 1,137 | |
| Capital Work in Progress | 165 | 62 | 78 | 307 |
| 32 | 87 | 107 | 77 | |
| 475 | 602 | 643 | 588 | |
| 0 | 0 | 519 | 575 | |
| Cash & Bank | 83 | 12 | 24 | 9 |
| 502 | 555 | 177 | 215 | |
| Total Assets | 2,040 | 2,244 | 2,582 | 2,906 |
| Total Debt | 339 | 214 | 264 | 396 |
| Net Working Capital | 447 | 562 | 651 | 665 |
| Contingent Liabilities | 0 | 7 | 7 | 14 |
| Book Value per Share | 53646.60 | 171.97 | 193.85 | 219.36 |
| Face Value | 10.00 | 5.00 | 5.00 | 5.00 |
| Total Debt | 339 | 214 | 264 | 396 |
| Net Working Capital | 447 | 562 | 651 | 665 |
| Contingent Liabilities | 0 | 7 | 7 | 14 |
| Book Value per Share | 53646.60 | 171.97 | 193.85 | 219.36 |
| Face Value | 10.00 | 5.00 | 5.00 | 5.00 |
Mar 2022
- Equity Capital
- 0
- 1,341
- 338
- Trade Payables
- 215
- 146
- Total Liabilities
- 2,040
- 782
- Capital Work in Progress
- 165
- 32
- 475
- 0
- Cash & Bank
- 83
- 502
- Total Assets
- 2,040
- Total Debt
- 339
- Net Working Capital
- 447
- Contingent Liabilities
- 0
- Book Value per Share
- 53646.60
- Face Value
- 10.00
- Total Debt
- 339
- Net Working Capital
- 447
- Contingent Liabilities
- 0
- Book Value per Share
- 53646.60
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 45
- 1,513
- 214
- Trade Payables
- 340
- 132
- Total Liabilities
- 2,244
- 926
- Capital Work in Progress
- 62
- 87
- 602
- 0
- Cash & Bank
- 12
- 555
- Total Assets
- 2,244
- Total Debt
- 214
- Net Working Capital
- 562
- Contingent Liabilities
- 7
- Book Value per Share
- 171.97
- Face Value
- 5.00
- Total Debt
- 214
- Net Working Capital
- 562
- Contingent Liabilities
- 7
- Book Value per Share
- 171.97
- Face Value
- 5.00
Mar 2024
- Equity Capital
- 45
- 1,711
- 264
- Trade Payables
- 378
- 183
- Total Liabilities
- 2,582
- 1,033
- Capital Work in Progress
- 78
- 107
- 643
- 519
- Cash & Bank
- 24
- 177
- Total Assets
- 2,582
- Total Debt
- 264
- Net Working Capital
- 651
- Contingent Liabilities
- 7
- Book Value per Share
- 193.85
- Face Value
- 5.00
- Total Debt
- 264
- Net Working Capital
- 651
- Contingent Liabilities
- 7
- Book Value per Share
- 193.85
- Face Value
- 5.00
Mar 2025
- Equity Capital
- 45
- 1,943
- 293
- Trade Payables
- 278
- 348
- Total Liabilities
- 2,906
- 1,137
- Capital Work in Progress
- 307
- 77
- 588
- 575
- Cash & Bank
- 9
- 215
- Total Assets
- 2,906
- Total Debt
- 396
- Net Working Capital
- 665
- Contingent Liabilities
- 14
- Book Value per Share
- 219.36
- Face Value
- 5.00
- Total Debt
- 396
- Net Working Capital
- 665
- Contingent Liabilities
- 14
- Book Value per Share
- 219.36
- Face Value
- 5.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 0 | -44 | 250 | 216 | 332 | |
| Cash from Investing | 0 | -139 | -158 | -215 | -414 |
| Cash from Financing | 0 | 260 | -163 | 10 | 65 |
| 0 | 78 | -71 | 12 | -17 | |
| Free Cash Flow | 0 | -44 | 147 | 22 | -83 |
| OCF / Net Profit | -0.00 | -0.36 | 1.29 | 1.00 | 1.22 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
| OCF / Net Profit | -0.00 | -0.36 | 1.29 | 1.00 | 1.22 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 |
Mar 2021
- 0
- Cash from Investing
- 0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- 0
- OCF / Net Profit
- -0.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.00
- Cumulative 5-Year FCF
- 0
Mar 2022
- -44
- Cash from Investing
- -139
- Cash from Financing
- 260
- 78
- Free Cash Flow
- -44
- OCF / Net Profit
- -0.36
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.36
- Cumulative 5-Year FCF
- 0
Mar 2023
- 250
- Cash from Investing
- -158
- Cash from Financing
- -163
- -71
- Free Cash Flow
- 147
- OCF / Net Profit
- 1.29
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.29
- Cumulative 5-Year FCF
- 0
Mar 2024
- 216
- Cash from Investing
- -215
- Cash from Financing
- 10
- 12
- Free Cash Flow
- 22
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- 0
Mar 2025
- 332
- Cash from Investing
- -414
- Cash from Financing
- 65
- -17
- Free Cash Flow
- -83
- OCF / Net Profit
- 1.22
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.22
- Cumulative 5-Year FCF
- 0
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - |
| EPS (₹) | -0.18 | 4890.04 | 21.35 | 23.93 | 30.06 |
| Book Value (₹) | 9.12 | 53646.60 | 171.97 | 193.85 | 219.36 |
| Dividend per Share (₹) | 0.00 | 0.00 | 2.00 | 3.00 | 5.00 |
| Cash EPS (₹) | -0.18 | 6574.79 | 28.25 | 32.01 | 39.64 |
| PROFITABILITY | - | - | - | - | - |
| Operating Margin % | 0.00% | 17.46% | 17.70% | 20.84% | 21.96% |
| Net Margin % | 0.00% | 10.19% | 9.95% | 11.71% | 12.88% |
| ROE % | -2.02% | 18.23% | 13.35% | 13.08% | 14.55% |
| ROCE % | -1.87% | 19.40% | 16.11% | 16.75% | 17.59% |
| -1.84% | 11.98% | 9.03% | 8.99% | 9.93% | |
| EFFICIENCY | - | - | - | - | - |
| Debtor Days | 0 | 115 | 78 | 96 | 94 |
| Inventory Days | 0 | 145 | 101 | 123 | 106 |
| Payable Days | 0 | 61 | 86 | 128 | 106 |
| 0 | 198 | 92 | 90 | 94 | |
| FINANCIAL HEALTH | - | - | - | - | - |
| Debt to Equity (x) | 0.08x | 0.25x | 0.14x | 0.15x | 0.20x |
| Interest Coverage (x) | 0.00x | 13.99x | 13.39x | 18.46x | 14.41x |
| 11.42x | 1.77x | 1.94x | 1.94x | 2.01x | |
| GROWTH | - | - | - | - | - |
| Revenue Growth % | 0.00% | 0.00% | 62.11% | -4.76% | 14.17% |
| Operating Profit Growth % | 0.00% | 0.00% | 64.41% | 13.52% | 21.37% |
| Net Profit Growth % | 0.00% | 0.00% | 58.28% | 12.10% | 25.59% |
| 0.00% | 0.00% | 0.00% | 12.10% | 25.58% | |
| VALUATION | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 18.18x | 24.91x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 2.24x | 3.41x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.69% | 0.67% |
| 0.00x | 0.00x | 0.00x | 10.70x | 15.12x |
Mar 2021
- EPS (₹)
- -0.18
- Book Value (₹)
- 9.12
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -0.18
- Operating Margin %
- 0.00%
- Net Margin %
- 0.00%
- ROE %
- -2.02%
- ROCE %
- -1.87%
- -1.84%
- Debtor Days
- 0
- Inventory Days
- 0
- Payable Days
- 0
- 0
- Debt to Equity (x)
- 0.08x
- Interest Coverage (x)
- 0.00x
- 11.42x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 4890.04
- Book Value (₹)
- 53646.60
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6574.79
- Operating Margin %
- 17.46%
- Net Margin %
- 10.19%
- ROE %
- 18.23%
- ROCE %
- 19.40%
- 11.98%
- Debtor Days
- 115
- Inventory Days
- 145
- Payable Days
- 61
- 198
- Debt to Equity (x)
- 0.25x
- Interest Coverage (x)
- 13.99x
- 1.77x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 21.35
- Book Value (₹)
- 171.97
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 28.25
- Operating Margin %
- 17.70%
- Net Margin %
- 9.95%
- ROE %
- 13.35%
- ROCE %
- 16.11%
- 9.03%
- Debtor Days
- 78
- Inventory Days
- 101
- Payable Days
- 86
- 92
- Debt to Equity (x)
- 0.14x
- Interest Coverage (x)
- 13.39x
- 1.94x
- Revenue Growth %
- 62.11%
- Operating Profit Growth %
- 64.41%
- Net Profit Growth %
- 58.28%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 23.93
- Book Value (₹)
- 193.85
- Dividend per Share (₹)
- 3.00
- Cash EPS (₹)
- 32.01
- Operating Margin %
- 20.84%
- Net Margin %
- 11.71%
- ROE %
- 13.08%
- ROCE %
- 16.75%
- 8.99%
- Debtor Days
- 96
- Inventory Days
- 123
- Payable Days
- 128
- 90
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 18.46x
- 1.94x
- Revenue Growth %
- -4.76%
- Operating Profit Growth %
- 13.52%
- Net Profit Growth %
- 12.10%
- 12.10%
- P/E (x)
- 18.18x
- P/B (x)
- 2.24x
- Dividend Yield %
- 0.69%
- 10.70x
Mar 2025
- EPS (₹)
- 30.06
- Book Value (₹)
- 219.36
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 39.64
- Operating Margin %
- 21.96%
- Net Margin %
- 12.88%
- ROE %
- 14.55%
- ROCE %
- 17.59%
- 9.93%
- Debtor Days
- 94
- Inventory Days
- 106
- Payable Days
- 106
- 94
- Debt to Equity (x)
- 0.20x
- Interest Coverage (x)
- 14.41x
- 2.01x
- Revenue Growth %
- 14.17%
- Operating Profit Growth %
- 21.37%
- Net Profit Growth %
- 25.59%
- 25.58%
- P/E (x)
- 24.91x
- P/B (x)
- 3.41x
- Dividend Yield %
- 0.67%
- 15.12x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-18 - Aarti Pharmalabs Limited has informed the Exchange about Copy of Newspaper Publication
- Record Date
2026-08-17 - Aarti Pharmalabs Limited has informed the Exchange that Record date for the purpose of Dividend is 15-Sep-2026.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
Jun 2026
May 2026